ClinVar Miner

Submissions for variant NM_000334.4(SCN4A):c.2635AAG[1] (p.Lys880del)

dbSNP: rs760403755
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV001756655 SCV001986223 uncertain significance not provided 2020-09-03 criteria provided, single submitter clinical testing In-frame deletion of 1 amino acids in a non-repeat region; In silico analysis supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 32660787, 27415035, 32798841)
Labcorp Genetics (formerly Invitae), Labcorp RCV002032775 SCV002248586 uncertain significance Hyperkalemic periodic paralysis 2024-09-03 criteria provided, single submitter clinical testing This variant, c.2638_2640del, results in the deletion of 1 amino acid(s) of the SCN4A protein (p.Lys880del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs760403755, gnomAD 0.09%). This variant has been observed in individual(s) with SCN4A-related conditions (PMID: 27415035, 32660787, 32798841, 35907044, 36116128, 36779057; internal data). ClinVar contains an entry for this variant (Variation ID: 1303156). Algorithms developed to predict the effect of variants on gene product structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects SCN4A function (PMID: 36116128). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Fulgent Genetics, Fulgent Genetics RCV005005271 SCV002778403 uncertain significance Potassium-aggravated myotonia; Paramyotonia congenita of Von Eulenburg; Hypokalemic periodic paralysis, type 2; Hyperkalemic periodic paralysis; Congenital myasthenic syndrome 16; Congenital myopathy 22A, classic; Congenital myopathy 22B, severe fetal 2024-05-20 criteria provided, single submitter clinical testing
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre RCV002032775 SCV004805696 uncertain significance Hyperkalemic periodic paralysis 2024-03-29 criteria provided, single submitter clinical testing
Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences RCV002267639 SCV002549809 uncertain significance SCN4A-related non-dystrophic myotonia 2022-04-06 no assertion criteria provided research
Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences RCV002032775 SCV002600057 uncertain significance Hyperkalemic periodic paralysis 2022-04-12 no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.